Aflac (NYSE:AFL – Free Report) had its price objective decreased by Piper Sandler from $122.00 to $118.00 in a research note ...
Piper Sandler, a well-known investment firm, increased its price target on shares of Amgen (NASDAQ:AMGN) to $329.00, up from the previous target of $310.00. The firm has maintained its Overweight ...
MINNEAPOLIS, February 06, 2025--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, announced today that its board of directors has authorized the repurchase of up to $150 million of ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
The U.S. Securities and Exchange Commission's (SEC) newly established Crypto Task Force is expected to provide much-needed regulatory clarity for institutional investors, according to a research note ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Piper Sandler analyst David Westenberg maintained a Hold rating on Idexx Laboratories (IDXX – Research Report) today and set a price target of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results